Overview
The Union Health Ministry has amended drug regulations to end the over-the-counter sale of cough syrups and other syrup-based medicines, making a doctor’s prescription mandatory. The change came into effect through the Drugs (Fifth Amendment) Rules, 2026, after removing “syrups” from Schedule K of the Drugs Rules, 1945.
A Big Change in Drug Rules
On 9 June 2026, the Union Health Ministry notified a significant amendment to the Drugs Rules, 1945. Under the Drugs (Fifth Amendment) Rules, 2026 , the word “syrups” has been removed from Schedule K . Schedule K is a list of medicines that were exempt from certain provisions of the Drugs and Cosmetics Act, 1940. This means that cough syrups and other syrup-based medicines can no longer be sold over the counter. From now on, you must have a valid prescription from a registered medical practitioner to buy them. The government says this step is necessary to strengthen regulatory oversight and prevent misuse.
What Was Schedule K?
Schedule K of the Drugs Rules, 1945, listed certain categories of drugs that were exempt from specific provisions of the Drugs and Cosmetics Act. These exemptions allowed some medicines to be sold without a prescription. For example, certain drugs used for minor ailments could be purchased directly from a pharmacy. Syrups were included in this list. This meant that cough syrups and other syrup formulations could be sold over the counter without a doctor’s prescription. Now, with syrups removed from Schedule K, they will be treated like other prescription drugs.
Why Was the Change Made?
The government has been concerned about the misuse of cough syrups for non-medical purposes. Some people consume cough syrups to get a high because they contain codeine or other sedative ingredients. This is a form of drug abuse. Also, there have been cases of cough syrups being exported to other countries and causing harm. In 2023, India faced global criticism after cough syrups manufactured in the country were linked to the deaths of children in Uzbekistan. The World Health Organisation (WHO) also issued alerts about contaminated cough syrups. These incidents prompted the government to tighten regulations.
The Amendment Process
The amendment did not happen overnight. On 29 December 2025, the government issued a draft notification. It invited suggestions and objections from stakeholders and the public. All comments received during the consultation process were examined. The final decision was made after consultation with the Drugs Technical Advisory Board (DTAB) . DTAB is the country’s apex technical body on drug regulation. After this thorough process, the Drugs (Fifth Amendment) Rules, 2026, were notified on 9 June 2026.
What This Means for Consumers
If you have a cough and need a syrup, you will now have to visit a doctor. You cannot simply walk into a pharmacy and buy it. The pharmacist will ask for a prescription. This may be inconvenient for minor coughs. But the government believes it is necessary to prevent misuse and ensure safety. It also means that doctors will have more control over what medicines patients take.
Impact on Pharmacies
Pharmacies will now have to strictly follow the new rules. They cannot sell any syrup formulation without a prescription. If caught violating the rule, they could face penalties under the Drugs and Cosmetics Act. The government may conduct inspections to ensure compliance. This is a big change for pharmacies that used to sell cough syrups freely.
A Human Touch: A Mother’s Concern
Let me share a story. Mrs. Sharma from Delhi has a 5-year-old son who gets a cough every winter. She used to buy a popular cough syrup from the local pharmacy without a prescription. Now, she will have to take her son to a doctor for every cough. This is a bit of a hassle. But she understands the reason. She says, “If this rule stops children from getting harmful medicines, I am fine with it. I will just keep a doctor’s number handy.” Her view reflects the mixed feelings many people have – inconvenience versus safety.
The Role of the Drugs Technical Advisory Board
DTAB played a key role in the decision. DTAB is the highest technical body on drug matters in India. It advises the government on drug standards, quality control, and regulation. The board includes experts from the medical and pharmaceutical fields. Their advice is taken very seriously. The fact that DTAB supported this amendment shows that it is based on scientific and medical evidence.
The Bigger Picture: Strengthening Drug Regulation
This amendment is part of a larger effort by the government to strengthen drug regulation in India. In recent years, there have been several cases of substandard and fake drugs. The government has been working to improve quality control, inspection, and enforcement. Making cough syrups prescription-only is one step in this direction. It shows that the government is serious about protecting public health.
Exam-Focused Points
-
New Rule: Cough syrups and other syrup-based medicines cannot be sold over the counter.
-
Notification: Drugs (Fifth Amendment) Rules, 2026, notified on 9 June 2026.
-
Legal basis: Amendment to the Drugs Rules, 1945.
-
Key change: “Syrups” removed from Schedule K of the Drugs and Cosmetics Act, 1940.
-
Result: Syrup formulations must be sold only on a valid prescription.
-
Consultation: Draft notification issued on 29 December 2025; public and stakeholder comments examined.
-
Advisory body: Drugs Technical Advisory Board (DTAB) consulted.
-
Reason: To prevent misuse, strengthen oversight, and prevent export of substandard syrups.
-
Background: Global concerns after 2023 Uzbekistan deaths and WHO alerts.
-
Schedule K: Earlier exempted certain drugs from strict prescription rules.
Frequently Asked Questions (FAQ)
Q1: Can I still buy cough syrup without a prescription?
A: No. Cough syrups and other syrup-based medicines can now be sold only on a valid prescription from a registered medical practitioner.
Q2: When did this rule come into effect?
A: The rule was notified on 9 June 2026 and came into effect immediately.
Q3: Why did the government make this change?
A: To prevent misuse of cough syrups (including drug abuse) and to strengthen regulatory oversight after global concerns about substandard syrups.
Q4: Does this apply to all syrups?
A: Yes, the amendment removes the word “syrups” from Schedule K, which means all syrup formulations are now covered under the prescription-only requirement.
Q5: What happens if a pharmacy sells syrup without a prescription?
A: The pharmacy can face penalties under the Drugs and Cosmetics Act. Government inspections may be conducted to ensure compliance.